Abstract

Cardiovascular disease prevention: Risk factor modification at the heart of the matter

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
Henry N Ginsberg ... William C Cushman
The American Journal of Cardiology | VOL. 99
Henry N Ginsberg, et. al.Henry N Ginsberg ... William C Cushman
12 Apr 2007
Dyslipidemia.
G.B John Mancini ... Robert A Hegele
Canadian journal of diabetes | VOL. Suppl 42 1
G.B John Mancini, et. al.G.B John Mancini ... Robert A Hegele
01 Apr 2018
Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum
S Mitchell Harman
Fertility and Sterility | VOL. 101
S Mitchell HarmanS Mitchell Harman
28 Mar 2014
Cardiovascular Disease in Children with Chronic Kidney Disease
Mark M Mitsnefes
Advances in Chronic Kidney Disease | VOL. 12
Mark M MitsnefesMark M Mitsnefes
01 Oct 2005
View more papers

More From: The Lancet Regional Health - Western Pacific

Paper Title
Journal
Date
Author
Assessing the generalisability of the psychosis metabolic risk calculator (PsyMetRiC) for young people with first-episode psychosis with validation in a Hong Kong Chinese Han population: a 4-year follow-up study
Wing Tse ... Sherry Kit Wa Chan
The Lancet Regional Health - Western Pacific | VOL. 47
Wing Tse, et. al.Wing Tse ... Sherry Kit Wa Chan
01 Jun 2024
The association between education and premature mortality in the Chinese population: a 10-year cohort study
Jifei Wang ... Maigeng Zhou
The Lancet Regional Health - Western Pacific | VOL. 47
Jifei Wang, et. al.Jifei Wang ... Maigeng Zhou
01 Jun 2024
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study
Min Xu ... Yu Hu
The Lancet Regional Health - Western Pacific | VOL. 47
Min Xu, et. al.Min Xu ... Yu Hu
01 Jun 2024
List prices and clinical value of anticancer drugs in China, Japan, and South Korea: a retrospective comparative study
Jay Pan ... Jing Zhou
The Lancet Regional Health - Western Pacific | VOL. 47
Jay Pan, et. al.Jay Pan ... Jing Zhou
01 Jun 2024
View more papers